Aminoflavone

N/A

Report date: 2024/01/25 09:17:24
NME

Base Information

Drug NameAminoflavone
Drug Alias NameAFP-464TK-2339NSC-71064NSC-686288NSC-0686288
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsSolid tumoursBreast Neoplasms, MaleBreast Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTigris PharmaceuticalsNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsSolid tumoursBreast Neoplasms, MaleBreast Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A